Laurus Labs gets DRDO nod to make and market 2-Deoxy-D-glucose (2DG) in India

Laurus has applied with CDSCO for EUA of the drug

Laurus Labs announced that it has received the licence from Defence Research & Development Organisation (DRDO) to manufacture and market of 2-Deoxy-D-Glucose (2DG).

2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country.

Laurus Labs has already applied with CDSCO for emergency use authorization (EUA) for 2DG.

2-Deoxy-D-GlucoseCDSCODRDOEmergency Use AuthorizationLaurus Labs
Comments (0)
Add Comment